Target intelligence / Profile preview

Cell-surface α2,3- and α2,6-linked sialic acid residues (α2,3/α2,6-Sia)

Target
α2,3/α2,6-Sia
Molecular classification
Glycan, Carbohydrate, Post-translational modification, Cell surface receptor ligand
01

Overview

Cell-surface α2,3- and α2,6-linked sialic acid residues are terminal monosaccharides found on the glycan chains of glycoproteins and glycolipids. These residues play a critical role in biological recognition, serving as essential receptors for various pathogens, most notably the influenza virus, where α2,3-linkages are preferred by avian strains and α2,6-linkages by human strains (Long et al., 2019). In the context of oncology, many tumors exhibit hypersialylation, a process where an overabundance of these residues creates a "glycan shield" that interacts with Siglec receptors on immune cells to suppress the anti-tumor immune response (Läubli & Varki, 2020). Therapeutic strategies targeting these residues include the use of neuraminidase inhibitors to block viral egress and engineered sialidases, such as E-602, to strip these residues from the surface of cancer cells, thereby enhancing immune detection (Palleon Pharmaceuticals, 2023). Additionally, these residues are involved in cell-cell adhesion and inflammatory signaling pathways (Varki, 2008). Understanding the distribution and linkage types of these sialic acids is vital for developing targeted anti-infectives and next-generation cancer immunotherapies.

Other names
Sialic acid residuesNeu5Ac glycansSialylated glycoproteinsInfluenza virus receptorsSiglec ligandsα2,3-Siaα2,6-Sia
02

Mechanism of action

Enzymatic removal of sialic acid residues (desialylation) to prevent pathogen entry or disrupt immune-suppressive Siglec signaling; competitive inhibition of viral neuraminidase to prevent the release of viral progeny from sialylated host cell surfaces.

03

Biological functions

Cell-cell recognitionPathogen attachment and entryImmune response modulationSignal transductionCell adhesionProtein stability and trafficking
04

Disease associations

Infection (e.g., Influenza, COVID-19, Cholera)Cancer (Immune evasion and metastasis)InflammationAutoimmune disease
05

Safety considerations

Off-target desialylation of healthy tissuesPotential for systemic pro-inflammatory responsesImmunogenicity of recombinant sialidase proteinsAlteration of normal physiological cell-cell adhesion
06

Interacting drugs

Oseltamivir

5 more in the full profile.

07

Biomarkers

Sialyl-Lewis X (sLeX) expressionSialyl-Tn antigen (STn) levelsSiglec-7/9 ligand density on tumor cellsTotal serum sialic acid (TSA)α2,3/α2,6 linkage ratios in respiratory epithelium

Beyond the preview

Go deeper on Cell-surface α2,3- and α2,6-linked sialic acid residues (α2,3/α2,6-Sia).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-surface α2,3- and α2,6-linked sialic acid residues (α2,3/α2,6-Sia).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call